Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Harvard Retinal Imaging Lab, Boston, MA, USA.
Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Harvard Retinal Imaging Lab, Boston, MA, USA; Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Prog Retin Eye Res. 2021 Sep;84:100951. doi: 10.1016/j.preteyeres.2021.100951. Epub 2021 Jan 28.
The advent of optical coherence tomography (OCT) revolutionized both clinical assessment and research of vitreoretinal conditions. Since then, extraordinary advances have been made in this imaging technology, including the relatively recent development of swept-source OCT (SS-OCT). SS-OCT enables a fast scan rate and utilizes a tunable swept laser, thus enabling the incorporation of longer wavelengths than conventional spectral-domain devices. These features enable imaging of larger areas with reduced motion artifact, and a better visualization of the choroidal vasculature, respectively. Building on the principles of OCT, swept-source OCT has also been applied to OCT angiography (SS-OCTA), thus enabling a non-invasive in depth-resolved imaging of the retinal and choroidal microvasculature. Despite their advantages, the widespread use of SS-OCT and SS-OCTA remains relatively limited. In this review, we summarize the technical details, advantages and limitations of SS-OCT and SS-OCTA, with a particular emphasis on their relevance for the study of retinal conditions. Additionally, we comprehensively review relevant studies performed to date to the study of retinal health and disease, and highlight current gaps in knowledge and opportunities to take advantage of swept source technology to improve our current understanding of many medical and surgical chorioretinal conditions. We anticipate that SS-OCT and SS-OCTA will continue to evolve rapidly, contributing to a paradigm shift to more widespread adoption of new imaging technology to clinical practice.
光学相干断层扫描 (OCT) 的出现彻底改变了玻璃体视网膜疾病的临床评估和研究。从那时起,这项成像技术取得了非凡的进展,包括最近出现的扫频源 OCT(SS-OCT)。SS-OCT 具有快速扫描速度和可调谐扫频激光,因此能够纳入比传统光谱域设备更长的波长。这些特点分别实现了更大区域的成像,减少了运动伪影,以及脉络膜血管的更好可视化。基于 OCT 的原理,扫频源 OCT 也已应用于 OCT 血管造影 (SS-OCTA),从而能够对视网膜和脉络膜微血管进行非侵入性的深度分辨成像。尽管具有这些优势,SS-OCT 和 SS-OCTA 的广泛应用仍然相对有限。在这篇综述中,我们总结了 SS-OCT 和 SS-OCTA 的技术细节、优势和局限性,特别强调了它们在研究视网膜疾病方面的相关性。此外,我们全面回顾了迄今为止针对视网膜健康和疾病进行的相关研究,并强调了当前知识空白和利用扫频源技术的机会,以提高我们对许多医学和外科脉络膜视网膜疾病的现有认识。我们预计 SS-OCT 和 SS-OCTA 将继续快速发展,推动新成像技术更广泛地应用于临床实践的范式转变。